Publications

Sort by: Date | Author | Title

Pozzo, E., Yedigaryan, L., Giarratana, N., Wang, C. C., Garrido, G. M., Degreef, E., Marini, V., Rinaldi, G., van der Veer, B. K., Sassi, G., Eelen, G., Planque, M., Fanzani, A., Koh, K. P., Carmeliet, P., Yustein, J. T., Fendt, S. M., Uyttebroeck, A. & Sampaolesi, M. (2025). miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Reports, 44(1), Article 115171. https://doi.org/10.1016/j.celrep.2024.115171
Rahmdel, S., Türkoglu, T., Nikjoo, N., Babaali, E., Moradi Mirhesari, D., Nega, M., Brüggemann, H., Huang, L., Witte Paz, M., Nieselt, K. & Götz, F. (2025). Beyond commensalism: genomic insights into micrococcin P1-producing Staphylococcus chromogenes. mSphere, 10(12), 1-32. Article e0073325. https://doi.org/10.1128/msphere.00733-25
Ramiro, S., Poddubnyy, D., Mease, P. J., López-Medina, C., Kim, M., Massow, U., Taieb, V., Kragstrup, T. W. & McGonagle, D. (2025). Sustained resolution of enthesitis and peripheral arthritis over 104 weeks with bimekizumab in axial spondyloarthritis. RMD Open, 11(4), Article e005969. https://doi.org/10.1136/rmdopen-2025-005969
Rasmussen, AA., Nordestgaard, KL., Simonsen, U. & Buus, NH. (2025). Blood Pressure–Lowering Effects of Aldosterone Synthase Inhibitors—A Systematic Review. Basic and Clinical Pharmacology and Toxicology, 137(2), Article e70080. https://doi.org/10.1111/bcpt.70080
Rasmussen, D. K., Sun, Y. J., Franco, J. A., Kumar, A., Vu, J. T., Bassuk, A. G. & Mahajan, V. B. (2025). Structure-function analysis of CNGA3-associated achromatopsia patient variants complements clinical genomics in pathogenicity determination. Orphanet Journal of Rare Diseases, 20(1), Article 261. https://doi.org/10.1186/s13023-025-03792-3
Reeg, S., Klefter, O. N., Subhi, Y., Vorum, H., Honoré, B. & Cehofski, L. J. (2025). Proteomics analysis of aqueous and vitreous humor in uveitis: a systematic literature review. Clinical Proteomics, 23(1), Article 3. https://doi.org/10.1186/s12014-025-09564-2
Reinhardt, J., Dankbar, B., Geers, F., Werbenko, E., Geyer, C., Bleckmann, A., Menck, K., Grözinger, A., Hartmann, W., Tio, J., Höltke, C., Helfen, A., Lodberg, A., Al-Qasemi, R., Beckmann, D., Bödecker, S., Kleimann, S., Wessendorf, L., Wawersig, D. ... Wehmeyer, C. (2025). Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models. Oncogene, 44(49), 4781–4795. https://doi.org/10.1038/s41388-025-03622-7
Ring, T., Rees, S. E. & Frische, S. (2025). Revelations from charge-balance modeling. Scandinavian Journal of Clinical and Laboratory Investigation, 85(6), 452-461. https://doi.org/10.1080/00365513.2025.2559345
Ritoré-Salazar, F., Arenas, A. M., Matia-González, A. M., Zaza, A., Thomsen, E. A., Rovsing, A. B., Mikkelsen, J. G., Noguera, N. I. & Medina, P. P. (2025). PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP. Biomarker Research, 13(1), Article 112. https://doi.org/10.1186/s40364-025-00815-w
Ruijs, T. Q., de Cuba, C. M. K. E., Heuberger, J. A. A. C., Hutchison, J., Bold, J., Grønnebæk, T. S., Jensen, K. G., Chin, E., Quiroz, J. A., Petersen, T. K., Flagstad, P., de Kam, M. L., van Esdonk, M. J., Klaassen, E., Doll, R. J., Koopmans, I. W., de Goede, A. A., Aulin, L. B. S., Pedersen, T. H. & Groeneveld, G. J. (2025). Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial. Clinical Pharmacology and Therapeutics, 117(3), 768-778. https://doi.org/10.1002/cpt.3516